Carter Bankshares (CARE)
(Delayed Data from NSDQ)
$20.00 USD
+1.97 (10.93%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $20.00 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.00 USD
+1.97 (10.93%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $20.00 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Zacks News
Carter Bankshares (CARE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares (CARE) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Carter Bankshares, Inc. (CARE) Meets Q3 Earnings Estimates
by Zacks Equity Research
Carter Bankshares (CARE) delivered earnings and revenue surprises of 0% and 3.07%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
BCB Bancorp (BCBP) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
BCB Bancorp (BCBP) delivered earnings and revenue surprises of 12.50% and 3.49%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for October 10th
by Zacks Equity Research
CARE, AMTB and GMS have been added to the Zacks Rank #5 (Strong Sell) List on October 10, 2024.
New Strong Sell Stocks for October 3rd
by Zacks Equity Research
BLMN, CJEWY and CARE have been added to the Zacks Rank #5 (Strong Sell) List on October 3, 2024.
New Strong Sell Stocks for September 16th
by Zacks Equity Research
CARE, AMKR and CAL have been added to the Zacks Rank #5 (Strong Sell) List on September 16 2024.
Is the Options Market Predicting a Spike in Carter Bankshares (CARE) Stock?
by Zacks Equity Research
Investors need to pay close attention to Carter Bankshares (CARE) stock based on the movements in the options market lately.
Compared to Estimates, Carter Bankshares (CARE) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Carter Bankshares (CARE) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Carter Bankshares, Inc. (CARE) Meets Q2 Earnings Estimates
by Zacks Equity Research
Carter Bankshares (CARE) delivered earnings and revenue surprises of 0% and 2.31%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Take the Zacks Approach to Beat the Markets: NVIDIA, Seagate, Amkor in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Carter Bankshares (CARE) Soars 5.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Carter Bankshares (CARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Surging Earnings Estimates Signal Upside for Carter Bankshares (CARE) Stock
by Zacks Equity Research
Carter Bankshares (CARE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
How Much Upside is Left in Carter Bankshares (CARE)? Wall Street Analysts Think 28.92%
by Zacks Equity Research
The mean of analysts' price targets for Carter Bankshares (CARE) points to a 28.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Implied Volatility Surging for Carter Bankshares (CARE) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Carter Bankshares (CARE) stock based on the movements in the options market lately.
Wall Street Analysts See a 30.85% Upside in Carter Bankshares (CARE): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 30.9% upside potential for Carter Bankshares (CARE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Compared to Estimates, Carter Bankshares (CARE) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares (CARE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cambridge (CATC) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Cambridge (CATC) delivered earnings and revenue surprises of -2.86% and 1.42%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares, Inc. (CARE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Blue Foundry Bancorp (BLFY) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Blue Foundry Bancorp (BLFY) delivered earnings and revenue surprises of 7.14% and 1.12%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares, Inc. (CARE) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Carter Bankshares, Inc. (CARE) Meets Q3 Earnings Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 0% and 1.59%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Equity Bancshares (EQBK) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Equity Bancshares (EQBK) delivered earnings and revenue surprises of 5.26% and 2.30%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of -61.29% and 29.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Carter Bankshares, Inc. (CARE) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 9.68% and 2.38%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?